简体中文
EnglishWhat Does NIDA.NIH.GOV Say About Medications for Opioid Use Disorder?
Updated
NIDA.NIH.GOV states that medications for opioid use disorder (MOUD) are safe, effective, and save lives. The site presents this through a NIDA-produced video that takes a closer look at these medications and how they work, and it places the topic within its broader clinical resources for substance use and addiction science. This is general educational information from a federal research institute, not a personal treatment recommendation—anyone seeking care should consult a qualified clinician and use the treatment locator described below.
What the site says
The core message on the MOUD page is short and direct:
- Medications for opioid use disorder are safe.
- They are effective.
- They save lives.
The page pairs this statement with a video that explains what these medications are and how they work. The framing is educational: it is meant to help a general audience understand that medication is a legitimate part of treatment, not a substitute for it.
Where this fits on the site
The MOUD content sits inside NIDA's public-facing science and clinical resources, not in its grant or research-program sections. Related entry points on the homepage include:
| Section | What it offers |
|---|---|
| Medications for Opioid Use Disorder | Video and explanation of MOUD |
| NIDAMED: Clinical Resources | Substance use screening tools and guidelines |
| Opioids / Fentanyl (under Explore Topics) | Background on specific substances |
| Looking for Treatment? | SAMHSA Treatment Locator and helpline |
That placement matters: NIDA frames MOUD as part of a continuum that runs from research, to clinical tools, to actually finding care.
If you are looking for treatment
The site does not provide treatment itself. Instead, it points readers to the SAMHSA Treatment Locator or the helpline 1-800-662-HELP (4357). Use those when the question shifts from "what are these medications" to "where can I or someone else get them."
What the page does not cover
Based on the available page content, the MOUD section is an overview rather than a detailed clinical guide. It does not lay out dosing, specific drug comparisons, or eligibility criteria. For those details, the site's clinical resources (NIDAMED) and the treatment locator are the more appropriate next stops.